23 Jul 2010
In 2005, two Tdap vaccines were licensed in the United States: ADACEL (sanofi pasteur, Swiftwater, Pennsylvania) for use in persons aged 11–64 years and BOOSTRIX (GlaxoSmithKline Biologicals, Rixensart, Belgium) for persons aged 10–18 years. Both vaccines are licensed for single-dose administration.
I copied this info from: http://www.cdc.gov/mmwr/pdf/rr/rr57e0514.pdf; where you could get more info., hope this helps?
- Boostrix (Tdap) Information for Consumers
- Boostrix (Tdap) Information for Healthcare Professionals (includes dosage details)
- Side Effects of Boostrix (Tdap) (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
The vaccination guidleines are very confusing with regard to using the adult dose of the Boostrix Tdap vaccine. If we only stock this Tdap, is it ...
0 answers • 28 Jul 2011
Why haven't the results on 300mg studies been released yet? Supposed to submitted by March of this year? Can't afford 400 dollars for 30day ...
2 answers • 19 Nov 2013